Skip to Content

Elekta AB Class B EKTAF

Morningstar Rating
$6.13 −0.32 (4.96%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

EKTAF is trading at a 790% premium.
Price
$6.12
Fair Value
$9.62
Uncertainty
Very High
1-Star Price
$38.51
5-Star Price
$9.74
Economic Moat
Hqdwml
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if EKTAF is a good fit for your portfolio.

Trading Information

Previous Close Price
$6.45
Day Range
$6.136.13
52-Week Range
$6.138.40
Bid/Ask
$5.99 / $6.41
Market Cap
$2.34 Bil
Volume/Avg
332 / 1,967

Key Statistics

Price/Earnings (Normalized)
15.65
Price/Sales
1.38
Dividend Yield (Trailing)
3.69%
Dividend Yield (Forward)
3.77%
Total Yield
3.69%

Company Profile

Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,000 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 31%; Europe, the Middle East, and Africa accounting for 35%; and the Asia-Pacific contributing the remainder.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Core
Total Number of Employees
4,607

Competitors

Valuation

Metric
EKTAF
ISRG
BDX
Price/Earnings (Normalized)
15.6569.6119.42
Price/Book Value
2.3810.662.67
Price/Sales
1.3820.953.51
Price/Cash Flow
9.3554.7919.36
Price/Earnings
EKTAF
ISRG
BDX

Financial Strength

Metric
EKTAF
ISRG
BDX
Quick Ratio
0.694.030.78
Current Ratio
1.005.151.41
Interest Coverage
4.244.31
Quick Ratio
EKTAF
ISRG
BDX

Profitability

Metric
EKTAF
ISRG
BDX
Return on Assets (Normalized)
4.53%14.89%3.59%
Return on Equity (Normalized)
13.61%17.17%7.46%
Return on Invested Capital (Normalized)
9.82%15.09%5.23%
Return on Assets
EKTAF
ISRG
BDX
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
XmyncspcTfps$156.8 Bil
Becton Dickinson & Co
BDX
BtvkkhgrjYcvtjck$68.6 Bil
Alcon Inc
ALC
LydsyjwfJxrhwv$46.5 Bil
Coloplast A/S ADR
CLPBY
QhjqcywcqJnhvt$29.1 Bil
ResMed Inc
RMD
HnfqjzwtdGzycf$28.9 Bil
West Pharmaceutical Services Inc
WST
NkxmgscmyKdmtz$20.7 Bil
The Cooper Companies Inc
COO
MmzwhqrMrdhj$18.6 Bil
Hologic Inc
HOLX
VjqrhgnmGlvpnw$18.4 Bil
Baxter International Inc
BAX
LtcgfvmBfnrll$18.1 Bil
Teleflex Inc
TFX
XfqmLwbz$10.4 Bil

Sponsor Center